Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Organisation › Details

Oxford Science Enterprises plc

Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via its unique partnership with the University of Oxford, the world’s #1 research university. This partnership enables OSE to work with the brightest academic minds tackling the world’s toughest challenges and guarantees unrivalled access to their scientific research. In collaboration with its global network of entrepreneurs and advisers, OSE goes well beyond funding to shape and nurture these complex ideas into successful businesses. Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, and Deep Tech – the company adopts a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience. To date, OSE has invested £0.5 billion in over 80 ambitious companies built on Oxford science, helping progress 28 from seed to Series A, and 22 to Series B and beyond, including 2 IPOs and 7 trade sales. A key player in Oxford’s entrepreneurial ecosystem, OSE is highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. *

 

Period Start 2015-05-01 established pred
  Group Oxford Science Enterprises (Group)
  Predecessor Oxford Sciences Innovation plc (OSI)
Products Industry IP services
  Industry 2 venture capital
     
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  Street 46 Woodstock Road
  City OX22 6HT Oxford, Oxfordshire
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
  Currency USD
  Annual sales 800,000,000 (capital, evergreen (2020) 2020-12-09)
     
    * Document for »About Section«: Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford.
     
   
Record changed: 2024-07-04

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x300px




» top